Literature DB >> 22790645

Dietary fat modulates the testosterone pharmacokinetics of a new self-emulsifying formulation of oral testosterone undecanoate in hypogonadal men.

Anthony Yin1, Eman Alfadhli, Michelle Htun, Robert Dudley, Sandra Faulkner, Laura Hull, Andrew Leung, Rachelle Bross, James Longstreth, Ronald Swerdloff, Christina Wang.   

Abstract

This study investigates the effect of dietary fat on the testosterone (T) pharmacokinetics in hypogonadal men following administration of a self-emulsifying capsule formulation of oral T undecanoate (TU). In an open-label, 2-center, 5-way crossover study, a single oral dose of TU containing 300-mg equivalents of T (maximum anticipated human dose per administration) was administered to 16 hypogonadal men with a washout period of at least 5 days between doses. All participants were randomized to receive the TU capsules fasting or 30 minutes after an approximately 800-calorie meal containing 10%, 20%, 30%, or 50% fat. Serial blood samples were collected from 2 hours predose to 25 hours postdose to determine serum T and dihydrotestosterone (DHT) by liquid chromatography tandem mass spectrometry. Administering TU with a meal increased serum T concentrations, with the magnitude of the increase being directly dependent on the amount of fat in the meal. Average and peak serum T concentrations and area under the curve increased as the fat content of the meal was increased. Neither the high-fat meal (50% fat) nor the lower-fat meal (20% fat) showed a significant food effect relative to the normal-fat (Western diet) meal (30% fat). However, administering TU while fasting resulted in 50% or less of the cumulative exposure obtained when administered with 20%- to 50%-fat meals (albeit still substantial). A very-low-fat meal (10% fat) showed a significant food effect relative to the normal meal, but still exceeded the fasting condition by approximately 50%. Serum DHT concentrations showed corresponding increases to the serum T. As expected with the maximum anticipated clinical dose of TU (300 mg T), oral administration of this new formulation with food containing 20% to 50% dietary fat produced T levels at or above the upper range of adult men, and T levels trended higher as dietary fat content increased. Only with a very-low-fat diet (10%) or in a fasted state did a clinically significant food effect occur, but even then sufficient TU was absorbed with the self-emulsifying TU formulation to produce average serum T concentration predicted to be in the normal reference range (10 to 35 nmol/L).

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22790645      PMCID: PMC4170073          DOI: 10.2164/jandrol.112.017020

Source DB:  PubMed          Journal:  J Androl        ISSN: 0196-3635


  14 in total

1.  Diurnal rhythms of serum total, free and bioavailable testosterone and of SHBG in middle-aged men compared with those in young men.

Authors:  Michael J Diver; Komal E Imtiaz; Aftab M Ahmad; Jiten P Vora; William D Fraser
Journal:  Clin Endocrinol (Oxf)       Date:  2003-06       Impact factor: 3.478

2.  Important effect of food on the bioavailability of oral testosterone undecanoate.

Authors:  Wilma M Bagchus; Rita Hust; Frans Maris; Peter G Schnabel; Natalie S Houwing
Journal:  Pharmacotherapy       Date:  2003-03       Impact factor: 4.705

3.  Testosterone undecanoate: a new orally active androgen.

Authors:  C Hirschhäuser; C R Hopkinson; G Sturm; A Coert
Journal:  Acta Endocrinol (Copenh)       Date:  1975-09

4.  Loss of circadian rhythmicity in blood testosterone levels with aging in normal men.

Authors:  W J Bremner; M V Vitiello; P N Prinz
Journal:  J Clin Endocrinol Metab       Date:  1983-06       Impact factor: 5.958

5.  Androgen replacement with oral testosterone undecanoate in hypogonadal men: a double blind controlled study.

Authors:  N E Skakkebaek; J Bancroft; D W Davidson; P Warner
Journal:  Clin Endocrinol (Oxf)       Date:  1981-01       Impact factor: 3.478

6.  Reexamination of pharmacokinetics of oral testosterone undecanoate in hypogonadal men with a new self-emulsifying formulation.

Authors:  Anthony Y Yin; Michelle Htun; Ronald S Swerdloff; Maruja Diaz-Arjonilla; Robert E Dudley; Sandra Faulkner; Rachelle Bross; Andrew Leung; Sima Baravarian; Laura Hull; James A Longstreth; Steven Kulback; Gregory Flippo; Christina Wang
Journal:  J Androl       Date:  2011-04-07

7.  Lymphatic absorption and metabolism of orally administered testosterone undecanoate in man.

Authors:  H J Horst; W J Höltje; M Dennis; A Coert; J Geelen; K D Voigt
Journal:  Klin Wochenschr       Date:  1976-09-15

8.  Effect of testosterone supplementation on functional mobility, cognition, and other parameters in older men: a randomized controlled trial.

Authors:  Marielle H Emmelot-Vonk; Harald J J Verhaar; Hamid R Nakhai Pour; André Aleman; Tycho M T W Lock; J L H Ruud Bosch; Diederick E Grobbee; Yvonne T van der Schouw
Journal:  JAMA       Date:  2008-01-02       Impact factor: 56.272

9.  Dimethandrolone undecanoate: a new potent orally active androgen with progestational activity.

Authors:  Barbara J Attardi; Sheri A Hild; Jerry R Reel
Journal:  Endocrinology       Date:  2006-02-23       Impact factor: 4.736

10.  The effect of food composition on serum testosterone levels after oral administration of Andriol Testocaps.

Authors:  Peter G Schnabel; Wilma Bagchus; Holger Lass; Torben Thomsen; T B Paul Geurts
Journal:  Clin Endocrinol (Oxf)       Date:  2007-04       Impact factor: 3.478

View more
  11 in total

1.  Effect of fat on serum 25-hydroxyvitamin D levels after a single oral dose of vitamin D in young healthy adults: a double-blind randomized placebo-controlled study.

Authors:  Fabiana Viegas Raimundo; Maria Augusta Britto Lang; Luciano Scopel; Natália Aydos Marcondes; Mirna Griselda Anocibar Araújo; Gustavo Adolpho Moreira Faulhaber; Tania Weber Furlanetto
Journal:  Eur J Nutr       Date:  2014-05-23       Impact factor: 5.614

2.  An update on male hypogonadism therapy.

Authors:  Prasanth Surampudi; Ronald S Swerdloff; Christina Wang
Journal:  Expert Opin Pharmacother       Date:  2014-04-23       Impact factor: 3.889

Review 3.  Cross-sex hormone therapy for gender dysphoria.

Authors:  B Fabris; S Bernardi; C Trombetta
Journal:  J Endocrinol Invest       Date:  2014-11-18       Impact factor: 4.256

4.  Single, escalating dose pharmacokinetics, safety and food effects of a new oral androgen dimethandrolone undecanoate in man: a prototype oral male hormonal contraceptive.

Authors:  Prasanth Surampudi; Stephanie T Page; Ronald S Swerdloff; Jean Jacques Nya-Ngatchou; Peter Y Liu; John K Amory; Andrew Leung; Laura Hull; Diana L Blithe; Jason Woo; William J Bremner; Christina Wang
Journal:  Andrology       Date:  2014-05-02       Impact factor: 3.842

Review 5.  Testosterone Replacement Therapy in Hypogonadal Men.

Authors:  Christina Wang; Ronald S Swerdloff
Journal:  Endocrinol Metab Clin North Am       Date:  2022-02-08       Impact factor: 4.741

Review 6.  Pharmacokinetics of testosterone therapies in relation to diurnal variation of serum testosterone levels as men age.

Authors:  Alexander W Pastuszak; Marc Gittelman; James P Tursi; Jonathan S Jaffe; David Schofield; Martin M Miner
Journal:  Andrology       Date:  2021-10-08       Impact factor: 4.456

7.  A New Oral Testosterone Undecanoate Formulation Restores Testosterone to Normal Concentrations in Hypogonadal Men.

Authors:  Ronald S Swerdloff; Christina Wang; William B White; Jed Kaminetsky; Marc C Gittelman; James A Longstreth; Robert E Dudley; Theodore M Danoff
Journal:  J Clin Endocrinol Metab       Date:  2020-08-01       Impact factor: 5.958

8.  Strawberry Decreases Intraluminal and Intestinal Wall Hydrolysis of Testosterone Undecanoate.

Authors:  Atheer Zgair; Yousaf Dawood; Suhaib M Ibrahem; Jong Bong Lee; Wanshan Feng; Peter M Fischer; Pavel Gershkovich
Journal:  Molecules       Date:  2021-01-05       Impact factor: 4.411

9.  Safety and Pharmacokinetics of Single-Dose Novel Oral Androgen 11β-Methyl-19-Nortestosterone-17β-Dodecylcarbonate in Men.

Authors:  Sherry Wu; Fiona Yuen; Ronald S Swerdloff; Youngju Pak; Arthi Thirumalai; Peter Y Liu; John K Amory; Feng Bai; Laura Hull; Diana L Blithe; Bradley D Anawalt; Toufan Parman; Kyuri Kim; Min S Lee; William J Bremner; Stephanie T Page; Christina Wang
Journal:  J Clin Endocrinol Metab       Date:  2019-03-01       Impact factor: 6.134

10.  Accurate measurement of androgen after androgen esters: problems created by ex vivo esterase effects and LC-MS/MS interference.

Authors:  J Ceponis; R Swerdloff; A Leung; L Hull; F Bai; J Longstreth; R Dudley; T Danoff; C Wang
Journal:  Andrology       Date:  2018-10-21       Impact factor: 4.456

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.